`IPR2014-01088
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`GLOBALFOUNDRIES U.S., INC., GLOBALFOUNDRIES DRESDEN
`MODULE ONE LLC & CO. KG, GLOBALFOUNDRIES DRESDEN
`MODULE TWO LLC & CO. KG, and THE GILLETTE COMPANY,
`Petitioners
`
`v.
`
`ZOND, LLC,
`Patent Owner
`
`_____________________
`Case No. IPR2014-010881
`
`Patent 6,806,652 B2
`
`_____________________
`
`PATENT OWNER’S OBSERVATIONS ON CROSS-EXAMINATION
`OF PETITIONER’S REPLY WITNESS
`
`37 C.F.R. §42.70
`
`
`
`
`
`
`
`
`
`!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
`1 Case IPR2014-01000 has been joined with the instant proceeding.
`
`
`
`
`
`Patent No. 6,806,652
`IPR2014-01088
`
`
`Pursuant to 37 C.F.R. §42.70(a), Patent Owner, Zond, LLC, hereby
`
`submits it observations on cross-examination of Dr. Korthsagen, whose
`
`Declaration was submitted by Petitioners with their Reply Brief filed June 26,
`
`2015. Dr. Kortshagen’s cross-examination was conducted by deposition on
`
`July 2, 2015. Exhibit 2003 is a transcript of that deposition, and is used as the
`
`basis for the present observations.
`
`
`
`1.!
`
`Dr. Kortshagen Testified that Mozgrin’s Regions 2 and 3 Both
`Represent Areas of High-Density Plasma.
`
`
`Claim 1 of the ‘652 patent requires “super-ionizing [an] initial plasma so as
`
`to generate a high-density plasma.”2 According to Petitioner, a person of ordinary
`
`skill in the art would have found it obvious to substitute the device of Fahey in the
`
`preexcitation unit of Iwamura to generate such an initial plasma.3 That is,
`
`Petitioner specifies the initial plasma as that which is produced by the
`
`preexcitation unit.4 Dr. Kortshagen testified that region 1 of Mozgrin’s Fig. 4 is
`
`!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
`2 Ex. 1001 at 33:63-64; see also, Ex. 2003 at 10:5-23.
`
`3 Pet. at 54-55.
`
`4 Id. at 55; see also, Ex. 2003 at 46:12 – 51:23 (Dr. Kortshagen specifying that
`
`2
`
`
`
`representative of such an initial plasma created by a preexcitation unit.5 Dr.
`
`Patent No. 6,806,652
`IPR2014-01088
`
`
`Kortshagen further testified that region 2 of Mozgrin’s Figure 4 represents an area
`
`of high-density plasma,6 and that region 3 of Mozgrin’s Figure 4 also represents
`
`an area of high-density plasma.7 This testimony is relevant because it contradicts
`
`Petitioner’s argument that Mozgrin teaches “super-ionizing the initial plasma so
`
`as to generate a high-density plasma.”8
`
`In an attempt to show “super-ionization” of the initial plasma, Dr.
`
`Kortshagen and Petitioner rely on computations that discuss the plasma densities
`
`during a transition from Mozgrin’s region 2 to region 3.9 For example, Dr.
`
`Kortshagen states that “‘for the discharge transit from regime 2 to regime 3 . . . the
`
`!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
`although it may not be visible, a plasma is produced in Iwamura’s preexcitation
`
`unit.).
`
`5 Ex. 2003 at 22:16-24:18 (testifying that region 1 shown in Mozgrin’s Figure 4
`
`represents a pre-ionization stage, with an initial plasma having a density in the
`
`range 107 – 109 cm-3).
`
`6 Id. at 26:3-21; 28:7-17.
`
`7 Id. at 28:19 – 29:8.
`
`8 Reply Brief at 2 et seq.
`
`9 Ex. 1020 at ¶ 31; Reply Brief at 10-11, 17.
`
`3
`
`
`
`ionization degree α = ne / (ng + ni) ranges from α ≈ 1 (p = 0.01 torr) to α ≈ 0.7 (p
`
`Patent No. 6,806,652
`IPR2014-01088
`
`
`= 1torr).’”10 However, Dr. Korshagen’s deposition testimony reveals that such a
`
`transition is not super-ionizing an initial plasma, as required by claim 1, rather it
`
`is further ionizing an already high-density plasma. That is, Dr. Kortshagen’s
`
`reliance on the densities reported by Mozgrin for a “discharge transit from regime
`
`2 to regime 3” do not support “converting at least 75% of the neutral atoms in the
`
`initial plasma into ions,”11 as the Board has determined is required by the claim.
`
`Rather, the “discharge transit from regime 2 to regime 3” represents ionization of
`
`an already dense plasma, not ionization of an initial plasma.
`
`
`
`2.!
`
`Dr. Kortshagen Testified that Mozgrin’s Region 1 Represents An
`Area of a Weakly-Ionized Plasma.
`
`
`Claim 1 of the ‘652 patent requires “super-ionizing [an] initial plasma so as
`
`to generate a high-density plasma,”12 and claim 4 specifies that the initial plasma
`
`!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
`10 Ex. 1020 at ¶ 31 quoting Mozgrin at 407, left col. ¶ 2 and right col. ¶ 3 (emphasis
`
`in original).
`
`11 Globalfoundries U.S., Inc. et al. v. Zond, LLC, IPR2014-01088, Paper 16, p. 11
`
`(P.T.A.B. Jan. 6, 2015).
`
`12 Ex. 1001 at 33:63-64; see also, Ex. 2003 at 10:5-23.
`
`4
`
`
`
`is a weakly-ionized plasma.13 Dr. Kortshagen testified that region 1 of Mozgrin’s
`
`Patent No. 6,806,652
`IPR2014-01088
`
`
`Fig. 4 is representative of such an initial plasma created by a preexcitation unit.14
`
`Dr. Kortshagen further testified that region 2 of Mozgrin’s Figure 4 represents an
`
`area of high-density plasma,15 and that region 3 of Mozgrin’s Figure 4 also
`
`represents an area of high-density plasma.16 This testimony is relevant because it
`
`contradicts Petitioner’s argument that claim 4 is obvious in view of the cited
`
`references.17
`
`In an attempt to show “super-ionization” of the initial plasma, Dr.
`
`Kortshagen and Petitioner rely on computations that discuss the plasma densities
`
`during a transition from Mozgrin’s region 2 to region 3.18 For example, Dr.
`
`Kortshagen states that “‘for the discharge transit from regime 2 to regime 3 . . . the
`
`!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
`13 Ex. 1001 at 34:5-6.
`
`14 Ex. 2003 at 22:16-24:18 (specified that region 1 shown in Mozgrin’s Figure 4
`
`represents a pre-ionization stage, with an initial plasma having a density in the
`
`range 107 – 109 cm-3).
`
`15 Id. at 26:3-21; 28:7-17.
`
`16 Id. at 28:19 – 29:8.
`
`17 Pet. at 54 et seq.
`
`18 Ex. 1020 at ¶ 31; Reply Brief at 10-11, 17.
`
`5
`
`
`
`ionization degree α = ne / (ng + ni) ranges from α ≈ 1 (p = 0.01 torr) to α ≈ 0.7 (p
`
`Patent No. 6,806,652
`IPR2014-01088
`
`
`= 1torr).’”19 However, Dr. Korshagen’s deposition testimony reveals that such a
`
`transition is not super-ionizing an initial, i.e., weakly-ionized plasma, as required
`
`by claim 4, rather it is further ionizing an already high-density plasma.
`
`
`
`3.!
`
`Dr. Kortshagen Testified that He Could Not Determine Whether
`Iwamura’s Preexcitaiton Unit Generated a Weakly-Ionized Plasma.
`
`
`During cross-examination, Dr. Kortshagen testified that he could not
`
`determine whether Iwamura’s pre-excitation unit creates a weakly-ionized plasma
`
`as defined in the ‘652 Patent.20 This testimony is relevant because it contradicts
`
`Petitioner’s argument that claim 4 is obvious in view of the cited references.21
`
`
`
`4.!
`
`Dr. Kortshagen’s Testimony Confirms that Iwamura’s Objective was
`to Treat an Object with “Active” Neutral Gas Atoms or Molecules,
`While Reducing the Risk of Damage by Ions.
`In his testimony,22 Dr. Korthsagen confirmed that Iwamura’s goal was to
`!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
`19 Ex. 1020 at ¶ 31 quoting Mozgrin at 407, left col. ¶ 2 and right col. ¶ 3 (emphasis
`
`in original).
`
`20 Ex. 2003 at 54:2-10.
`
`21 Pet. at 54 et seq.
`
`22 Ex. 2003 at 63:6 – 72:6; 76:6-16; 78:3 – 79:14.
`
`6
`
`
`
`treat an object with electrically neutral “activated species,” while minimizing
`
`Patent No. 6,806,652
`IPR2014-01088
`
`
`damage to the object caused by ions that are generated along with the activated
`
`species. This is relevant to Patent Owner’s explanation that the purpose of
`
`Iwamura’s two-stage system is NOT to super-ionize an initial plasma,23 and that
`
`Iwamura’s teaching is in fact contrary to this objective of the invention.
`
`First, Dr. Kortshagen explained that the “activated species” described by
`
`Iwamura are electrically neutral atoms/molecules that are in an excited energy
`
`state:24
`
`Q. Do you have an understanding of what Iwamura means by
`the term "activated gas species"?
`
`THE WITNESS: I believe what Iwamura refers to with
`"activated gas species" is can include excited atoms, excited
`molecules, potentially fragmented molecules, which would be
`called radicals.
`
`BY MR. FAHMI:
`
`Q. Are all of these electrically neutral?
`
`A. Yes, all of the ones that I named are electrically neutral.
`
`Dr. Kortshagen then confirmed that Iwamura’s goal was to treat a substrate or
`
`!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
`23 Patent Owner’s Opposition at 24-25.
`
`24 Id. at 60:4-16.
`
`7
`
`
`
`object with such electrically neutral molecules that are formed by a plasma:
`
`Patent No. 6,806,652
`IPR2014-01088
`
`
`Q. Yes. So, generally, then, Iwamura's goal is to treat the
`substrate or the object to be treated with the activated gas
`species that are formed by the plasma in order to improve the
`yield of the treatment, correct?
`
`. . .
`
`THE WITNESS: Yes, I believe that this is a fair statement,
`yes.25
`
`Dr. Kortshagen further testified that Iwamura discloses two techniques for
`
`reducing the damage caused by charged particles in the plasma so as to limit
`
`damage to the object by the ions26 - both of which are contrary to the claimed
`
`objective of super-ionizing a plasma. Dr. Korshagen confirmed that the first of
`
`these techniques removed the majority of charged particles from the plasma27 (thus
`
`reducing plasma density), and that the other reduced the power in the down stream
`
`stage (which also is contrary to the claimed super-ionization of a plasma).28 All of
`
`!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
`25 Id. at 64:19 – 65:3; see also, id. at 78:3-14.
`
`26 Id. at 76:6-16; 69:9 – 72: 6.
`
`27 Id. at 76:6-16.
`
`28 Id. at 69:9 – 72: 6; see 94:24 – 96:4 regarding the use of high power in the ‘652
`
`patent for super-ionization.
`
`8
`
`
`
`this confirms Patent Owner’s explanation that the purpose of Iwamura’s two-stage
`
`Patent No. 6,806,652
`IPR2014-01088
`
`
`system is NOT to super-ionize an initial plasma and that Iwmura’s teachings are
`
`contrary to this objective.
`
`
`
`5.!
`
`Dr. Kortshagen Confirmed that Fahey Does Not Teach Super-
`Ionization.
`Dr. Kortshagen’s testimony confirms Patent Owner’s characterization29 that
`
`the purpose of Fahey’s device was not to produce a high-density plasma, as
`
`claimed, but instead to produce electrically neutral, metastable atoms. Indeed, Dr.
`
`Kortshagen admitted that “it is correct that Fahey is a reference that is not geared
`
`towards super-ionization . . . .”30
`
`
`
`6.!
`
`Dr. Kortshagen Confirmed that the Power Supply of Claim 5 is the
`Power Supply Used to Super-Ionize The Plasma in Claim 1.
`Dr. Kortshagen’s testimony confirms Patent Owner’s argument31 that claim
`
`5 requires that the power supply that generates the electric field super-ionizing the
`
`initial plasma so as to generate the high-density plasma comprise an RF power
`
`supply. In particular, Dr. Kortshagen testified that a person of ordinary skill in the
`!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
`29 Patent Owner’s Opposition at 22-23.
`
`30 Ex. 2003 at 86:13 – 18 (emphasis added).
`
`31 Patent Owner’s Opposition at 31.
`
`9
`
`
`
`Patent No. 6,806,652
`IPR2014-01088
`
`art would understand the power supply recited in Element D of Claim 1 to generate
`
`an electric field that super-ionizes the initial plasma so as to generate a high-
`
`density plasma,32 and that this is the same power supply recited in claim 5.33 This
`
`confirms Patent owner’s argument that, “Claim 5 is not concerned with a power
`
`supply for generating an initial plasma, rather the claim is concerned with
`
`characteristics of a power supply for super-ionizing an initial plasma and
`
`generating a high-density plasma.”34
`
`
`
`
`
`Date: July 20, 2015
`
`Respectfully submitted,
`
`
`
`
`
`
`
`/Tarek Fahmi/
`Tarek N. Fahmi
`Reg. No. 41,402
`333 W. San Carlos Street, Suite 200
`San Jose, CA 95110
`408-799-0612
`tarek.fahmi@ascendalaw.com
`
`Counsel for Patent Owner Zond, LLC
`
`
`!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
`32 Ex. 2003 at 91:25 – 92:16.
`
`33 Id. at 93:6-11.
`
`34 Patent Owner’s Opposition at 32.!
`
`10
`
`
`
`Patent No. 6,806,652
`IPR2014-01088
`
`
`EXHIBIT LIST
`Description
`
`Exhibit
`No.
`Ex. 2001 Affidavit of Maria Granovsky in Support of Patent Owner’s Motion
`for Pro Hac Vice Admission
`
`Ex. 2002 Declaration of Larry D. Hartsough, Ph.D.
`
`Ex. 2003 Deposition of Uwe Kortshagen, Ph.D.
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing:
`
`Patent No. 6,806,652
`IPR2014-01088
`
`
`PATENT OWNER’S OBSERVATIONS ON CROSS-EXAMINATION
`OF PETITIONER’S REPLY WITNESS
`
`was served on July 20, 2015, by filing this document though the Patent Review
`
`Processing System as well as delivering a copy via EMAIL directed to the attorneys of
`
`record for the Petitioner at the following address:
`
`For Petitioner:
`GLOBALFOUNDRIES U.S., INC.,
`GLOBALFOUNDRIES DRESDEN
`MODULE ONE LLC & CO. KG, and
`GLOBALFOUNDRIES DRESDEN
`MODULE TWO LLC & CO. KG
`David M. Tennant
`WHITE & CASE LLP
`701 THIRTEENTH STREET, NW
`WASHINGTON, DC 20005
`dtennant@whitecase.com
`dchankong@whitecase.com
`
`
`For Petitioner:
`THE GILETTE COMPANY
`David L. Cavanaugh, Reg. No. 36,476
`Larissa Park, Reg. No. 59,051
`Wilmer Cutler Pickering Hale and
`Dorr LLP
`60 State Street
`Boston, MA 02109
`Tel: (617) 526-5000
`Email:
`david.cavanaugh@wilmerhale.com;
`Larissa.Park@wilmerhale.com
`
`
`The parties have agreed to electronic service in this matter.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`by:
`
`
`Respectfully submitted,
`
`
`
`
` /Tarek N. Fahmi/
`Tarek N. Fahmi, Reg. No. 41,402
`
`
`
`
`
`Date: July 20, 2015
`
`
`
`
`Ascenda Law Group, PC
`333 W. San Carlos Street, Suite 200
`San Jose, CA 95110
`Tel: 866 877 4883